Detection of gyrA mutation among clinical isolates of campylobacter jejuni isolated in Egypt by MAMA PCR

Journal of Infection in Developing Countries

Volumn 4, Issue 9, 2010, Pages 546-554

  Said, Mayar M ^a   El Mohamady, Hanan ^a   El Beih, Fawkia M ^b   Rockabrand, David M ^a   Ismail, Tharwat F ^c   Monteville, Marshall R ^a,d   Ahmed, Salwa F ^a   Klena, John D ^a,e   Salama, Mohamed S ^b  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b Ain Shams University   (Egypt)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Naval Environmental and Preventative Medical Unit 2   (United States)

^e IEIP CDC (China)   (United States)

Author keywords

Africa; Fluoroquinolone resistance; Mismatch sequence detection

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; THREONINE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; EGYPT; EPSILOMETER TEST; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GYRA GENE; NONHUMAN; POLYMERASE CHAIN REACTION;

CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI;

EID: 78049455170     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.963     Document Type: Article

References (32)

1. Wasfy MO, Oyofo BA, David JC, Ismail TF, el-Gendy AM, Mohran ZS, Sultan Y, Peruski LF Jr (2000) Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. Journal of Health, Population and Nutrition 18: 33-38.
2. Taylor DN, Sanchez JL, Candler W, Thornton S, McQueen C, Echeverria P (1991) Treatment of traveler's diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 114: 731-34.
3. Sjögren E, Linblom G-B, Kaijser B (1997) Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J Antimicrob Chemother 40: 257-61.
4. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT (1999) Quinolone resistant Campylobacter jejuni infections in Minnesota, 1992-1998. New Engl J Med 340: 1525-32.
5. Hooper DC (1999) Mechanisms of fluoroquinolone resistance. Drug Resistance Updates 2: 38-55.
6. Wang Y, Huang WM, Taylor DE (1993) Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother 37: 457-63.
7. Eaves DJ, Liebana E, Woodward MJ, Piddock LJ (2002) Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. Journal of Clinical Microbiology 40: 4121-5.
8. Alonso R, Mateo E, Girbau C, Churruca E, Martinez I, Férnandez-Astorga A (2004) PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli. Antimicrob Agents Chemother 48: 4886-88.
9. Wilson DL, Abner SR, Newman TC, Mansfield LS, Linz JE (2000) Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay. Journal of Clinical Microbiology 38: 3971-78.
10. Cha RS, Zarbi H, Keohavong P, Thilly WG (1992) Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods and Applications 2: 14-20.
11. Zirnstein G, Li Y, Swaminathan B, Angulo F (1999) Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. Journal of Clinical Microbiology 37: 3276-80.
12. Putnam SD, Frenck RW, Riddle MS, El-Gendy A, Taha NN, Pittner BT, Abu-Elyazeed R, Wierzba TF, Rao MR, Savarino SJ, Clemens JD (2003) Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. Diagnostic Microbiology and Infectious Disease 47: 601-608.
13. Klena JD, Parker CT, Knibb K, Ibbitt JC, Devane PM, Horn ST, Miller WG, Konkel ME (2004) Differentiation of Campylobacter coli, Campylobacter jejuni, Campylobacter lari, and Campylobacter upsaliensis by a multiplex PCR developed from the nucleotide sequence of the lipid A gene lpxA. Journal of Clinical Microbiology 42: 5549-57.
14. CLSI (2005) Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute. Report No.: M100-S15.
15. NARMS (2003) Human isolates final report In: US Department of Health and Human Services C, ed.: CDC.
16. Englen MD and Kelley LC (2000) A rapid DNA isolation procedure for the identification of Campylobacter jejuni by the polymerase chain reaction. Lett Appl Microbiol 31: 421-6.
17. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 41: 95-8.
18. Swaminathan B, Barrette TJ, Hunter SB, Tauxe RV (2001) Pulse Net: the molecular subtyping network for food born bacterial disease surveillance, United States. Emerg Infect Dis 7: 382-89.
19. Engberg J, Aaerstrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I (2001) Quinolone and macrolide resistance in Campylobacter jejuni and Campylobacter coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 7: 24-34.
20. Hart C and Kariuki S (1998) Antimicrobial resistance in developing countries. British Medical Journal 317: 647-50.
21. Albert MJ, Neil L, Pazhoor AA, Haridas S, Rotimi VO, Khan I (2005) Ciprofloxacin resistance and its molecular mechanism in Campylobacter spp. isolated in Kuwait. Microbial Drug Resistance 11: 266-70.
22. Nachamkin I, Ung H, Li M (2002) Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerg Infect Dis 8: 1501-3.
23. Everett MJ and Piddock LJ (1998) Mechanisms of resistance to fluoroquinolones. In: Kuhlmann J, Dahlhoff A, Zeiler HJ, eds. Quinolone antibacterials. Berlin: Springer-Verlag KG.
24. Drlica K and Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61: 377-92.
25. Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jörgensen F, Piddock LJV (2005) Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents Chemother 49: 699-707.
26. Guévrement E, Nadeau E, Sirois M, Quessy S (2006) Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers. Canadian Journal of Veterinary Research 2: 1-6.
27. Lucey B, Cryan B, O'Halloran F, Wall PG, Buckley T, Fanning S (2002) Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin. Veterinary Record 151: 1501-3.
28. Payot S, Cloeckaert A, Chaslus-Dancia E (2002) Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microbial Drug Resistance 8: 335-43.
29. Zirnstein G, Helsel L, Li Y, Swaminathan B, Besser J (2000) Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. FEMS Microbiol Lett 190: 1-7.
30. Chan K, Elhanafi D, Kathariou S (2008) Genomic evidence for interspecies acquisition of chromosomal DNA from Campylobacter jejuni by Campylobacter coli strains of a turkey-associated clonal group (cluster II). Foodborne Path Dis 5: 387-98.
31. Meinersmann RJ, Dingle KE, Maiden MC (2003) Genetic exchange among Campylobacter species. Genome Lett 2: 48-52.
32. Chu YW, Chu MY, Luey KY, Ngan YW, Tsang KL, Kam KM (2004) Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong. Journal of Clinical Microbiology 42: 3321-3.